Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Peroxovanadium compounds as inhibitors of angiogenesis.
Doillon CJ, Faure RL, Posner BI, Savard PE. Doillon CJ, et al. Among authors: faure rl. Angiogenesis. 1999;3(4):361-9. doi: 10.1023/a:1026577418765. Angiogenesis. 1999. PMID: 14517416
Human vascular endothelial cells with extended life spans: in vitro cell response, protein expression, and angiogenesis.
Gagnon E, Cattaruzzi P, Griffith M, Muzakare L, LeFlao K, Faure R, Béliveau R, Hussain SN, Koutsilieris M, Doillon CJ. Gagnon E, et al. Angiogenesis. 2002;5(1-2):21-33. doi: 10.1023/a:1021573013503. Angiogenesis. 2002. PMID: 12549857
Insulin-dependent phosphorylation of DPP IV in liver. Evidence for a role of compartmentalized c-Src.
Bilodeau N, Fiset A, Poirier GG, Fortier S, Gingras MC, Lavoie JN, Faure RL. Bilodeau N, et al. Among authors: faure rl. FEBS J. 2006 Mar;273(5):992-1003. doi: 10.1111/j.1742-4658.2006.05125.x. FEBS J. 2006. PMID: 16478473
Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation.
Blanchette J, Racette N, Faure R, Siminovitch KA, Olivier M. Blanchette J, et al. Eur J Immunol. 1999 Nov;29(11):3737-44. doi: 10.1002/(SICI)1521-4141(199911)29:11<3737::AID-IMMU3737>3.0.CO;2-S. Eur J Immunol. 1999. PMID: 10556830
Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: studies on a neuronal and a glial cell line.
Faure R, Vincent M, Dufour M, Shaver A, Posner BI. Faure R, et al. J Cell Biochem. 1995 Nov;59(3):389-401. doi: 10.1002/jcb.240590310. J Cell Biochem. 1995. PMID: 8567756
Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide.
Matte C, Marquis JF, Blanchette J, Gros P, Faure R, Posner BI, Olivier M. Matte C, et al. Eur J Immunol. 2000 Sep;30(9):2555-64. doi: 10.1002/1521-4141(200009)30:9<2555::AID-IMMU2555>3.0.CO;2-X. Eur J Immunol. 2000. PMID: 11009089
Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.
Posner BI, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Lum BS, et al. Posner BI, et al. J Biol Chem. 1994 Feb 11;269(6):4596-604. J Biol Chem. 1994. PMID: 8308031
Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds.
Barbeau B, Bernier R, Dumais N, Briand G, Olivier M, Faure R, Posner BI, Tremblay M. Barbeau B, et al. J Biol Chem. 1997 May 16;272(20):12968-77. doi: 10.1074/jbc.272.20.12968. J Biol Chem. 1997. PMID: 9148903
Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression.
Olivier M, Romero-Gallo BJ, Matte C, Blanchette J, Posner BI, Tremblay MJ, Faure R. Olivier M, et al. J Biol Chem. 1998 May 29;273(22):13944-9. doi: 10.1074/jbc.273.22.13944. J Biol Chem. 1998. PMID: 9593743
Protein tyrosine phosphatase inhibition induces anti-tumor activity: evidence of Cdk2/p27 kip1 and Cdk2/SHP-1 complex formation in human ovarian cancer cells.
Caron D, Savard PE, Doillon CJ, Olivier M, Shink E, Lussier JG, Faure RL. Caron D, et al. Among authors: faure rl. Cancer Lett. 2008 Apr 18;262(2):265-75. doi: 10.1016/j.canlet.2007.12.012. Epub 2008 Jan 30. Cancer Lett. 2008. PMID: 18234419
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback